Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Citi
Boehringer Ingelheim
Moodys
Cerilliant
Novartis
US Army
Daiichi Sankyo
Cantor Fitzgerald
Federal Trade Commission

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020570

« Back to Dashboard

NDA 020570 describes QUADRAMET, which is a drug marketed by Lantheus Medical and is included in one NDA. It is available from two suppliers. Additional details are available on the QUADRAMET profile page.

The generic ingredient in QUADRAMET is samarium sm-153 lexidronam pentasodium. Two suppliers are listed for this compound. Additional details are available on the samarium sm-153 lexidronam pentasodium profile page.
Summary for 020570
Tradename:QUADRAMET
Applicant:Lantheus Medical
Ingredient:samarium sm-153 lexidronam pentasodium
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020570
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QUADRAMET samarium sm-153 lexidronam pentasodium INJECTABLE;INJECTION 020570 NDA Lantheus Medical Imaging, Inc. 11994-016 11994-016-01 3 mL in 1 VIAL, SINGLE-DOSE (11994-016-01)
QUADRAMET samarium sm-153 lexidronam pentasodium INJECTABLE;INJECTION 020570 NDA Jazz Pharmaceuticals, Inc. 57902-860 57902-860-03 3 mL in 1 VIAL, SINGLE-DOSE (57902-860-03)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50mCi/ML
Approval Date:Mar 28, 1997TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Fish and Richardson
Boehringer Ingelheim
Covington
Teva
Moodys
Cerilliant
Merck
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot